Skip to content

CVRx, Inc. CVRX Free cash flow margin

Free cash flow margin at other companies

Abbott logo
AbbottABT
16.3%+0.6pp
Boston Scientific logo
Boston ScientificBSX
16.9%-0.3pp
Medtronic logo
MedtronicMDT
14.9%-0.5pp
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-10.3%-3.5pp
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-9.3%-1.7pp
Inspire Medical Systems logo
Inspire Medical SystemsINSP
10.6%+1.2pp

Other financials

Income statement

See full
Revenue$14.8M+19.6%
Gross profit$12.9M+24.9%
Operating income-$12.2M+9.5%
Net income-$13.1M+4.7%
EPS (diluted)-$0.50+5.7%

Balance sheet

See full
Cash & equivalents$72.3M-29.6%
Total debt$59.4M+17.8%
Total equity$29.1M-58.0%
Total assets$99.7M-23.0%

Cash flow

See full
Operating cash flow-$12.2M+4.7%
CapEx$122.0K+7.0%
Free cash flow-$12.3M+4.6%

Valuation

See full
Market cap$148.6M-2.9%
Enterprise value$135.69M+25.0%
P/S2.5×-0.3×

Profitability

See full
Gross margin86.2%+2.7pp
Operating margin-84.6%-8.9pp
Net margin-89.1%-7.0pp

Returns & leverage

See full
Return on equity-107%+73.4pp
Debt / equity+1.3×
Current ratio10.2×-4.6×

Where this comes from

Calculated from CVRx, Inc.’s reported figures.

Based on trailing twelve months.

The official record: CVRx, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about CVRx, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CVRx, Inc.'s free cash flow margin?
CVRx, Inc. (CVRX) reported free cash flow margin of -68% in Q1 2026.
How has CVRx, Inc.'s free cash flow margin changed year-over-year?
CVRx, Inc.'s free cash flow margin increased by 13.6% year-over-year, from -78.6% to -68%.
What is the long-term trend for CVRx, Inc.'s free cash flow margin?
Over 4 years (2021 to 2025), CVRx, Inc.'s free cash flow margin has grown at a -24.5% compound annual growth rate (CAGR), from -221.8% to -71.9%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.